Jilin Jian Yisheng Pharmaceutical Co., Ltd. (SHE:002566)

SHE:002566 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	624.12	665.38	850.63	829.06	875.14	841.51
Other Revenue	3.09	3.09	3.03	0.98	2.79	1.08
Revenue	627.21	668.47	853.66	830.04	877.93	842.59
Revenue Growth (YoY)	-21.90%	-21.69%	2.85%	-5.46%	4.19%	-16.80%
Cost of Revenue	167.72	174.13	224.8	215.44	221.22	217.11
Gross Profit	459.49	494.34	628.87	614.6	656.71	625.48
Selling, General & Admin	401.55	428.17	509.94	489.33	506.34	492.27
Research & Development	15.1	16.22	18.68	18.78	20.89	15.71
Other Operating Expenses	14.4	14	-6.62	16.5	15.96	13.96
Operating Expenses	431.05	458.4	522	525.88	542.74	528.08
Operating Income	28.44	35.95	106.86	88.73	113.97	97.4
Interest Expense	-13.84	-13.84	-13.66	-14.03	-13.36	-13.1
Interest & Investment Income	9.72	11.69	16.31	11.14	9.27	3.28
Currency Exchange Gain (Loss)	-0.14	-0.14	-0.12	-0	-	0.02
Other Non Operating Income (Expenses)	-2.6	0.23	-0.57	-1.92	0.13	-0.55
EBT Excluding Unusual Items	21.58	33.89	108.83	83.91	110.01	87.06
Gain (Loss) on Sale of Investments	8.03	6.41	2.39	-0.32	0.16	-
Gain (Loss) on Sale of Assets	0.29	0.29	0.78	-	-	-
Asset Writedown	-0.27	-0.27	-0.24	-0.27	-0.28	0.02
Other Unusual Items	19.22	19.22	0	17.9	13.48	17.96
Pretax Income	48.85	59.55	111.76	101.23	123.37	105.04
Income Tax Expense	7.57	8.89	15.65	12.91	18.67	15.42
Earnings From Continuing Operations	41.28	50.66	96.11	88.32	104.7	89.62
Minority Interest in Earnings	1.65	1.43	-1.38	-5.22	-8.68	-9.55
Net Income	42.93	52.09	94.73	83.1	96.02	80.06
Net Income to Common	42.93	52.09	94.73	83.1	96.02	80.06
Net Income Growth	-50.68%	-45.02%	14.00%	-13.46%	19.93%	4.52%
Shares Outstanding (Basic)	331	331	331	331	331	331
Shares Outstanding (Diluted)	331	331	331	331	331	331
Shares Change (YoY)	0.01%	-0.03%	0.02%	-0.02%	0.01%	-0.02%
EPS (Basic)	0.13	0.16	0.29	0.25	0.29	0.24
EPS (Diluted)	0.13	0.16	0.29	0.25	0.29	0.24
EPS Growth	-50.68%	-45.00%	13.98%	-13.44%	19.93%	4.54%
Free Cash Flow	27.69	43	173.36	104.49	108.04	127.58
Free Cash Flow Per Share	0.08	0.13	0.52	0.32	0.33	0.39
Dividend Per Share	0.100	0.100	0.150	0.050	0.030	0.030
Dividend Growth	-33.33%	-33.33%	200.00%	66.67%	-	-40.00%
Gross Margin	73.26%	73.95%	73.67%	74.05%	74.80%	74.23%
Operating Margin	4.54%	5.38%	12.52%	10.69%	12.98%	11.56%
Profit Margin	6.84%	7.79%	11.10%	10.01%	10.94%	9.50%
Free Cash Flow Margin	4.41%	6.43%	20.31%	12.59%	12.31%	15.14%
EBITDA	70.41	78.56	152.08	128.82	154.25	138.06
EBITDA Margin	11.22%	11.75%	17.82%	15.52%	17.57%	16.39%
D&A For EBITDA	41.96	42.61	45.21	40.09	40.28	40.67
EBIT	28.44	35.95	106.86	88.73	113.97	97.4
EBIT Margin	4.54%	5.38%	12.52%	10.69%	12.98%	11.56%
Effective Tax Rate	15.50%	14.93%	14.00%	12.75%	15.14%	14.68%
Revenue as Reported	668.47	668.47	853.66	830.04	877.93	842.59
Advertising Expenses	-	6.21	6.7	4.4	7.97	8.53

Source: S&P Global Market Intelligence. Standard template. Financial Sources.